2021 Meeting: The Genetics of Ocular Development (GoOD) Society
Hosts: Dra. Carmen Ayuso & Dra. Marta Corton (virtually in Madrid); Co-organisers: Nicola Ragge, Patrick Calvas & Nicolas Chassaing.
Programme: Third GoOD Meeting 2021
Friday, October 8, 2021
10 am – 6 pm CEST
(9 am – 5 pm GMT)
Host: Carmen Ayuso& Marta Corton (virtually in Madrid)
Co-organisers: Nicola Ragge, Patrick Calvas, Nicolas Chassaing
10:00 - 10:10
INTRODUCTION (9:00-9:10 BST)
10:10 - 11:30
SESSION 1 - DEVELOPMENTAL EYE DISORDERS: OVERVIEW, DIAGNOSIS AND PATHWAYS
10:10 (10’+2’)
First evidence of the role of SOX2 in a cohort of 96 patients with Peters' anomaly. Bertrand Chesneau, Marion Aubert-Mucca, Félix Fremont, JacminePechmeja,Vincent Soler, Bertrand Isidor, Mathilde Nizon, Hélène Dollfus, Josseline Kaplan, Tiffany Busa, Didier Lacombe, Sophie Naudion, Jeanne Amiel, Marlène Rio, Tania Attie-Bitach, Cécile Lesage, Dominique Thouvenin, Godelieve Morel, Catherine Vincent-Delorme, Odile Boute, ClémenceVanlerberghe, Anne Dieux, Simon Boussion, Laurence Faivre, Lucile Pinson, Fanny Laffargue, Gwenaël Le Guyader, Guylène Le Meur, Fabienne Prieur, Victor Lambert, Beatrice Laudier, Carmen Ayuso, Marta Corton, Lucas Fares-Taie, Jean-Michel Rozet, Véronique Gaston, Claire Jeanton-Scaramouche, Delphine Dupin-Deguine, Patrick Calvas, Nicolas Chassaing, Julie Plaisancié.
CHU Toulouse, INSERM UMR 1056, Toulouse, France
10:22 (10’+2’)
Overview of Structural Eye Disease diagnostic gene variants in the DDD subcohort of individuals with developmental ocular anomalies (CAP study)
Dorine Bax*, Lidiya Talbot*, Fabiola Ceroni, Yesim Kesim, Richard Holt, Nicola Ragge
Oxford Brookes University, Oxford, UK / Birmingham Women’s and Children’s NHS Foundation Trust
10:34 (10’+2’)
Clinical and genetic analysis of new cases provides further understanding of SHH pathway associated disorders
Yesim Kesim, Lidiya Talbot, Fabiola Ceroni, Richard Holt, Dorine Bax, Cheryl Longman, Shane McKee, DraganaJosifova, Pradeep Vasudevan, Nicola Ragge
Oxford Brookes University, Oxford, UK / Birmingham Women’s and Children’s NHS Foundation Trust
10:46 (18’+2’)
Variants in the nuclear retinoic acid receptors RARa and RARbconfirm a phenotypic spectrum of syndromic developmental eye disorders
Richard J. Holt, Fabiola Ceroni, Dorine Bax, Lidiya Talboot, Frances Elmslie, Katherine Lachlan, Emma Wakeling, Astrid Weber, Jacques L Michaud, Nicola K Ragge
Oxford Brookes University, UK &CHU Sainte-Justine Research Center. Montréal, Canada
11:10(8’+2’)
Long-read whole genome sequencing reveals the first cryptic PAX6 inversion causing aniridia
Alejandra Damián, Alejandra Tamayo, Gonzalo Núñez-Moreno, Pablo Mínguez, Carmen Ayuso, Marta Corton
IIS-Fundación Jiménez Díaz University Hospital- CIBERER, Madrid, Spain
11:20(8’+2’)
Poretti-Boltshauser syndrome: a rare cause of (extremely) high myopia.
Mary van Schooneveld. The Bartiméus Zeist, the Netherlands.
11:30–12:00
COFFEE BREAK / CHAT SESSION
12:00 - 13:15
SESSION 2 - MODELLING EYE DISORDERS
12:00 (10’+2’)
Functional characterization of potentially spliceogenic variants in aniridia by minigenes and ex-vivo approaches.
Alejandra Tamayo, MariaTarilonte, Gonzalo Núñez, Carolina Ruiz, Cristina Villaverde, Jennifer Moya, Patricia Ramos, Saoud T Swafiri, Fiona Blanco-Kelly, Pablo Mínguez,Carmen Ayuso, Marta Corton
IIS-Fundación Jiménez Díaz University Hospital- CIBERER, Madrid, Spain
12:12 (10’+2’)
CRISPR-Cas9-mediated functional dissection of the zebrafish foxc1 regulatory landscape identifies critical conserved regions with a probable role in human disease
Jesús J. Ferre Fernández, SanaaMuheisen, Samuel Thompson, Elena V. Semina
Medical College of Wisconsin, Milwaukee, WI, USA.
12:24 (10’+2’)
Gene expression profiling of zebrafish mab21l2u517 mutants during the optic vesicle to optic cup transition
Cristian Sobarzo, Camila Weiss-Garrido, Stephen S Carter, Lisa Tucker, Joaquin Letelier, Juan-Ramón Martinez-Morales, Gaia Gestri, Stephen W Wilson, Leonardo E Valdivia
Universidad Mayor, Santiago, Chile
12:36 (10’+2’)
Retinal coloboma in yapnl13 mutants is due to reduced RPE contractility
NiccoloFioritti, Giulia Cazzagon, Lisa Tucker, Masa Tada, Alex Nechiporuk, Stephen W. Wilson*, Gaia Gestri*
University College of London, UK
12:48(10’+2’)
Crosstalk between mechanical cues and Notch-dependent gene expression in retinal development.
Cerys S Manning. University of Manchester, UK
13:00 (10’+2’)
Genetically engineered pluripotent stem cell retinal organoids mimic retinoblastoma development.
Agata Rozanska, Rodrigo Cerna-Chavez, Rachel Queen, Joseph Collin, Darin Zerti, BirtheDorgau, Chia Beh, Tracey Davey, Jonathan Coxhead, Rafiqul Hussain, Jumana Al-Aama, David H Steel, Nissim Benvenisty, Lyle Armstrong, Manoj Parulekar, Majlinda Lako. Biosciences Institute, Newcastle, UK.
13:15–14:15
LUNCH & CHAT
14:15 - 15:40
SESSION 3 – RETINAL DISEASES & GENE TERAPHY
14:15 (10’+2’)
Clinical and genetic findings in TRPM1-associated congenital stationary night blindness. Christos Iosifidis, Jingshu Liu, Theodora Gale, Jamie Ellingford, Christopher Campbell, Kate Chandler, Neil R. Parry, Graeme C. Black, Panagiotis I. Sergouniotis
University of Manchester, UK
14:27 (8’+2’)
Development of a next-generation genetic testing system to detect copy number variants and gene variants associated with Inherited Retinal Dystrophy.
Jacqueline Chan, Christina Taylor, Stephanie Carpenter, Jolyon Holdstock, James Reid, VenuPullabhatla, Ewa Marek, MiwakoOsawa, Hiroko Sato, TakanoriWashio, HayatoNiiro, Akiko Maeda, Graham Speight
OGT, Oxford, UK
14:37 (8’+2’)
AAV-sponge mediated downregulation of miR-181a/b exerts a gene-independent protection on photoreceptors degeneration in inherited retinal dystrophies.
Martina Di Guida, Irene Guadagnino, MariateresaPizzo, Marta Molinari, Sabrina Carrella, Sandro Banfi
Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy
14:49(10’+2’)
Functional annotation of the North Carolina macular dystrophy loci implicates non-coding sequence and structural variants in influencing retinal enhancers.
Stijn Van de Sompele, Eva D'haene, BurcuMunevverCicekdal, Sarah Vergult, Thijs Van der Snickt, Fadi S. Shaya, Kris Vleminckx, Petra Liskova, Kent W. Small, Elfride De Baere
Ghent University Hospital, Ghent, Belgium
15:01(10’+2’)
Interaction map of cis-regulatory elements controlling ABCA4 in human retina.
Soraya Kalayanamontri. Universidad Pablo de Olavide, Sevilla, Spain
15:13(10’+2’)
Investigating photoreceptor glycan-binding proteins to assist gene therapy.
Cécile Méjécase, LyesToualbi, MariyaMoosajee
University College of London, UK
15:25 (10’+2’)
miR-181a/b modulation as potential therapeutic approach for AMD treatment
Simona Brillante, Eva Cipollaro, Marta Molinari, Sandro Banfi,AlessiaIndrieri, Sabrina Carrella.
Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy
15:40–15:55
TEA BREAK & CHAT
15:55–16:00
INTRODUCTION TO GUEST SPEAKER
16:00 –16:45
SESSION 3 – INVITED LECTURE BY
PR. JEAN-MICHEL ROZET
"Therapeutic approaches to inherited retinal disorders"
French National Institute for Health and Medical Research (INSERM)
Head of the Laboratory Genetics in Ophthalmology - IMAGINE Institute Paris, France.
16:45
GoOD SOCIETY BUSINESS MEETING